Results 171 to 180 of about 817,997 (230)

Discovery of monoamine oxidase inhibitors by medicinal chemistry approaches.

Medchemcomm, 2019
Hong R, Li X.
europepmc   +1 more source

Psychedelics in neurosurgery: Potential utility in prevention, perioperative care, pain management, and neurorehabilitation. [PDF]

Surg Neurol Int
Garcia-Bitar A, Castañeda EJ, Buenrostro-Rangel JR, Vázquez-Flores AK, Santibañez-Patiño PD, Moreno-Jiménez S.   +5 more
europepmc   +1 more source

Centanafadine (Simtriyo®): a first-in-class triple reuptake inhibitor approved for attention-deficit/hyperactivity disorder (ADHD). [PDF]

Med Chem Res
Hu L.
europepmc   +1 more source

Dietary inhibitors of monoamine oxidase A

Journal of Neural Transmission, 2010
Inhibition of monoamine oxidase is one way to treat depression and anxiety. The information now available on the pharmacokinetics of flavonoids and of the components of tobacco prompted an exploration of whether a healthy diet (with or without smoking) provides active compounds in amounts sufficient to partially inhibit monoamine oxidase.
Sarah E, Dixon Clarke, Rona R, Ramsay
openaire   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Switching Monoamine Oxidase Inhibitors

Drug Intelligence & Clinical Pharmacy, 1985
Substituting one monoamine oxidase inhibitor for another is recommended only after a drug-free interval to avoid hypertensive emergencies. The evidence and mechanism firmly supporting this caution is lacking. We report a case where monoamine oxidase inhibitors were substituted without apparent adverse consequences.
B L, True, B, Alexander, B, Carter
openaire   +2 more sources